Vila C - Search Results

1

Symptoms, prevalence and impact of multiple sclerosis in younger patients: a multinational survey.

Patti F, Vila C. Patti F, et al. Among authors: vila c. Neuroepidemiology. 2014;42(4):211-8. doi: 10.1159/000360423. Epub 2014 May 7. Neuroepidemiology. 2014. PMID: 24821493

2

Spasticity in multiple sclerosis: results of a patient survey.

Oreja-Guevara C, González-Segura D, Vila C. Oreja-Guevara C, et al. Among authors: vila c. Int J Neurosci. 2013 Jun;123(6):400-8. doi: 10.3109/00207454.2012.762364. Epub 2013 Feb 18. Int J Neurosci. 2013. PMID: 23297730

3

Impact of Sativex(®) on quality of life and activities of daily living in patients with multiple sclerosis spasticity.

Arroyo R, Vila C, Dechant KL. Arroyo R, et al. Among authors: vila c. J Comp Eff Res. 2014 Jul;3(4):435-44. doi: 10.2217/cer.14.30. J Comp Eff Res. 2014. PMID: 25275238 Free article. Review.

4

Correlation between spasticity and quality of life in patients with multiple sclerosis: the CANDLE study.

Arroyo R, Massana M, Vila C. Arroyo R, et al. Among authors: vila c. Int J Neurosci. 2013 Dec;123(12):850-8. doi: 10.3109/00207454.2013.812084. Epub 2013 Jul 15. Int J Neurosci. 2013. PMID: 23819835

5

Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis.

Meuth SG, Vila C, Dechant KL. Meuth SG, et al. Among authors: vila c. Expert Rev Neurother. 2015;15(8):909-18. doi: 10.1586/14737175.2015.1067607. Epub 2015 Jul 11. Expert Rev Neurother. 2015. PMID: 26166264 Review.

6

Retrospective observational study of the management of multiple sclerosis patients with resistant spasticity in Spain: the '5E' study.

Arroyo R, Vila C, Clissold S. Arroyo R, et al. Among authors: vila c. Expert Rev Pharmacoecon Outcomes Res. 2011 Apr;11(2):205-13. doi: 10.1586/erp.11.6. Expert Rev Pharmacoecon Outcomes Res. 2011. PMID: 21476822

7

Effectiveness and Tolerability of THC/CBD Oromucosal Spray for Multiple Sclerosis Spasticity in Italy: First Data from a Large Observational Study.

Trojano M, Vila C. Trojano M, et al. Among authors: vila c. Eur Neurol. 2015;74(3-4):178-85. doi: 10.1159/000441619. Epub 2015 Nov 17. Eur Neurol. 2015. PMID: 26571097

8

Cost-effectiveness of Sativex in multiple sclerosis spasticity: new data and application to Italy.

Slof J, Ruiz L, Vila C. Slof J, et al. Among authors: vila c. Expert Rev Pharmacoecon Outcomes Res. 2015 Jun;15(3):379-91. doi: 10.1586/14737167.2015.1025759. Epub 2015 Mar 16. Expert Rev Pharmacoecon Outcomes Res. 2015. PMID: 25771713

9

Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity.

Haupts M, Vila C, Jonas A, Witte K, Álvarez-Ossorio L. Haupts M, et al. Among authors: vila c. Eur Neurol. 2016;75(5-6):236-43. doi: 10.1159/000445943. Epub 2016 May 10. Eur Neurol. 2016. PMID: 27160412 Clinical Trial.

10

The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis-related spasticity.

Celius EG, Vila C. Celius EG, et al. Among authors: vila c. Brain Behav. 2018 Apr 6;8(5):e00962. doi: 10.1002/brb3.962. eCollection 2018 May. Brain Behav. 2018. PMID: 29761015 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262 results

Search Page

Filters